However, abnormal behavior in these proteins can lead to neurodegenerative disorders, including Parkinson's disease, dementia and Huntington's disease. La Trobe University researcher Dr. Shouxiang ...

Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase III for Huntington Disease.